期刊文献+

静脉注射和气管内滴入博莱霉素诱导小鼠肺纤维化的差异 被引量:12

Comparison of Mouse Lung Fibrosis Induced by Intravenous Injection and Intratracheal Instillation of Bleomycin
下载PDF
导出
摘要 目的探讨静脉注射和气管内滴入博莱霉素(BLM)对小鼠肺纤维化形成的差异。方法8周龄雌性C57BL/6小鼠40只,随机分为静脉注射组(V组)20只、气管内滴入组(I组)20只,分别经尾静脉一次性注射BLM150 mg/kg和气管内滴入BLM5 mg/kg。观察每组小鼠生存率、肺组织病理改变及肺组织羟脯胺酸的含量。结果①V组和I组小鼠的生存率分别为50%和75%,两者间统计学无显著性差异(P>0.05)。②注射处置后28d,两组小鼠均形成广泛、稳定的间质纤维化病理改变,但I组主要分布在肺门和支气管周围,而V组主要分布在胸膜下及血管周围。肺纤维化病理评分I组与V组之间无显著的统计学差异(P>0.05)。③小鼠注射处置后28 d,V组与I组肺羟脯氨酸含量分别为634.4±67.1μg/g和696.6±41.2μg/g,两组间无显著的统计学差异(P>0.05)。结论利用BLM静脉注射和气管内滴入制备肺间质纤维化动物模型,纤维化形成的部位存在着一定的差异,而肺间质形成纤维化的程度和病理改变大致相同。 Objective To study the differences of bleomycin-induced pulmonary fibrosis in mice induced by intravenous injection and intratracheal instillation of bleomycin. Methods Forty C57BL/6 mice (female, 8 wk of age, 17 to 20 g body weight) were randomly divided into two groups (20 mice in each group) :in the group V, bleomycin was injected intravenously once in a dose of 150 mg/kg, and in the group I, bleomycin was instilled intratracheally in a dose of 5 mg/kg, respectively. The survival rate, pathological changes and hydroxyproline content in the lung tissue were observed. Results ( 1 ) The survival rate of the groups V and I were 50% and 75%, respectively, statiscally with a non-significant difference ( P 〉 0.05). (2) At 28 days after injection, fibrosis was widely and stably formed mainly in around the bronchia and bronchioles, especially, near the pulmonary hilar area, in the group I mice, however, the same changes were mainly seen under the pleura or perivascular pulmonary tissues in the mice of group V. The pathological score of pulmonary fibrosis was not significantly different between those two groups (P〉0.05). (3) At 28 days after bleomycin administration, the hydroxyproline content in mice of groups V and I were 634.4±67.1μg/g and 696.6 ± 41.2 μg/g, respectively, statistically with a non-significant difference between the two groups (P〉0.05). Conclusions The sites of pulmonary fibrosis in the mice are different between the mice induced by intravenous injection or intratracheal instillation of bleomycin. However, the pathological appearance of pulmonary fibrosis was similar in mice of those two groups.
出处 《中国实验动物学报》 CAS CSCD 2008年第3期176-178,I0003,共4页 Acta Laboratorium Animalis Scientia Sinica
基金 国家自然科学基金资助项目(编号:3010007630570812)
关键词 小鼠 近交C57BL 博莱霉素 肺间质纤维化 C57BL/6 mouse Bleomycin Pulmonary fibrosis
  • 相关文献

参考文献8

  • 1Ashcroft T, Simpson J, Timbren V. Simple method of estimating severity of pulmonary fibrosis on a numerical seale[ J]. J Clin Pathol, 1988, 41(4) :467 - 470.
  • 2Zhang XY, Shimura S, Masuda T, et al. Antisense oligonueleotides to NF-κB improve the survival in bleomycin-induced pneumopathy of mouse[J]. Am J Respir Crit Care Med, 2000, 162(4): 1561 - 1568.
  • 3张晓晔,志村早苗,增田辙,齐藤宏树.博莱霉素静脉注射制备小鼠肺间质纤维化模型[J].中国实验动物学报,2007,15(4):241-244. 被引量:11
  • 4Gharaee M, Ullenbruch M, Phan SH. Animal models of pulmonary fibrosis[J]. Methods Mol Med, 2005, 117:251-259.
  • 5Felix C, Jack G, Geoffrey J. Pulmonary fibrosis searching for model answers[J]. Am J Respir Cell Mol Biol, 2005, 33:9- 13.
  • 6Harrison J, Lazo J. High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis [ J ]. J Pharmacol Exp Ther, 1987, 243(3) : 1185 - 1194.
  • 7Harrison J, Lazo J. Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosis [ J ]. J Pharmacol Exp Ther, 1988, 247(3) : 1052 - 1058.
  • 8Ekimoto H, Takahashi K, Matsuda A, et al. Experimentally induced bleomycin pulmonary toxicity-comparison of the systemic (intraperitoneal) and local (intratracheal) administration [ J ]. Gala To Kagaku Ryoho, 1983, 10(12) :2550 - 2557.

二级参考文献17

  • 1李健,牛建昭,王继峰,李彧,Jack Gauldie,贲长恩.AdTGF-β_1^(223/225)气管内注射制备大鼠肺间质纤维化动物模型[J].中国实验动物学报,2006,14(1):5-7. 被引量:9
  • 2American Thoracic Society (ATS) and European Respiratory Society (ERS) Joint Statement.International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias[J].Am J Respir Crit Care Med,2002,165:277-304.
  • 3Gharaee M,Ullenbruch M,Phan SH.Animal models of pulmonary fibrosis[J].Methods Mol Med,2005,117:251-259.
  • 4Felix C,Jack G,Geoffrey J.Pulmonary fibrosis searching for model answers[J].Am J Respir Cell Mol Biol,2005,33:9-13.
  • 5Harrison J,Hoyt D,Lazo J.Acute pulmonary toxicity of bleomycin:DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice[J].Mol Pharmacol,1989,36:231-238.
  • 6Haston C,Amos C,King T,et al.Inheritance of susceptibility to bleomycin-induced pulmonary fibrosis in the mouse[J].Cancer Res,1996,56:2596-2601.
  • 7Denis J,Schrier D,Robin G,et al.The role of strain variation in murine Bleomycin-induced pulmonary fibrosis[J].Am Rev Respir Dis,1983,127:63-66.
  • 8Ashcroft T,Simpson J,Timbrell V.Simple method of estimating severity of pulmonary fibrosis on a numerical scale[J].J Clin Pathol,1988,41:467-470.
  • 9Zhang XY,Shimura S,Masuda T,et al.Antisense oligonucleotides to NF-κB improve the survival in Bleomycin-induced pneumopathy of mouse[J].Am J Respir Crit Care Med,2000,162(4):1561-1568.
  • 10Green D,Reagan K.Determination of hydroxyproline by high pressure liquid chromatography[J].Anal Biochem,1992,201:265-269.

共引文献10

同被引文献128

引证文献12

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部